Amanta Healthcare Ltd.

108.07

2.3 (2.1%)growUp

As on April 2, 2026
Sector
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap0 Cr
P/E Ratio29.67
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open105.35
High108.9
NSE SymbolAMANTA
Close108.07
Low102
BSE Symbol544502
Previous Years High/Low
1 Year High154.4
3 Year High154.4
5 Year High154.4
1 Year Low92
3 Year Low92
5 Year Low92

Technicals


IndicatorsValueSignal
5-DMA102.27Bullish
10-DMA99.3Bullish
20-DMA98.79Bullish
50-DMA101.93Bullish
100-DMA106.03Bullish
200-DMA---

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 29.67, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹611 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹2747 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 762398.6
No. of Shares: 7055 (Approx)
Performance:-23.8%
P/L: ₹-237601.4
NIFTY Performance: -2.3%
1 day Top Gainers
SymbolChange%
LATENTVIEW312.1(20%)
OLAELEC28.34(10%)
TATACHEM651.9(7%)
CARBORUNIV854(6%)
BSOFT370.85(6%)
1 Day Top Losers
SymbolChange%
KARURVYSYA272.65(-7%)
UBL1485.1(-6%)
PGEL454.45(-6%)
CGCL166.33(-6%)
SRF2416.1(-5%)
AMBER6281.5(-5%)
GRSE2255.3(-4%)
ASTERDM658.1(-4%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

37.6%

896.6

1 Month Performance

Beta Drugs Ltd.

31.6%

1387.2

1 Month Performance

Shilpa Medicare Ltd.

20.2%

388.9

1 Month Performance

Strides Pharma Science Ltd.

15.3%

971.15

1 Month Performance

Jagsonpal Pharmaceuticals Ltd.

13.2%

186.22

1 Month Performance

Balaxi Pharmaceuticals Ltd.

11.9%

21.12

1 Month Performance

Aurobindo Pharma Ltd.

10.2%

1333.7

1 Month Performance

Bliss GVS Pharma Ltd.

9.5%

234.18

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month